{"transactions":[{"id":688854,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-08-12T23:33:20.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":135000,"derivative":{"exercise_price":27.38,"expiration_date":"2036-08-10","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001933414-26-000120","document":"wk-form4_1786577597.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1769041/000193341426000120/wk-form4_1786577597.xml","form_type":"4"}},{"id":688853,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-12T23:33:20.000Z","date":"2026-08-10","kind":"grant","planned":false,"acquired":true,"shares":102400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant."}],"balance_after":102400,"source":{"system":"sec-edgar","filing":"0001933414-26-000120","document":"wk-form4_1786577597.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1769041/000193341426000120/wk-form4_1786577597.xml","form_type":"4"}},{"id":1279972,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options","published_at":"2025-02-06T21:51:35.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options to purchase 60,000 shares of common stock, which shall vest 1/4 on March 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant."}],"balance_after":60000,"derivative":{"exercise_price":19.75,"exercise_date":"2026-03-01","expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001213900-25-010973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1769041/000121390025010973/ownership.xml","form_type":"4"}},{"id":1708764,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2023-12-16T02:46:12.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024."}],"balance_after":1200000,"derivative":{"exercise_price":0.247,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0001493152-23-045168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223045168/ownership.xml","form_type":"4"}},{"id":2077374,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2022-12-22T16:17:54.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023."}],"balance_after":625000,"derivative":{"exercise_price":0.53,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001493152-22-036232","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315222036232/ownership.xml","form_type":"4"}},{"id":2471212,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2021-12-16T02:18:42.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":587600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022."}],"balance_after":587600,"derivative":{"exercise_price":0.92,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":587600},"source":{"system":"sec-edgar","filing":"0000905718-21-001605","document":"matinas_fm4dec142021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571821001605/matinas_fm4dec142021.xml","form_type":"4"}},{"id":2924946,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-04T23:30:08.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":575000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022."}],"balance_after":575000,"derivative":{"exercise_price":1.36,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":575000},"source":{"system":"sec-edgar","filing":"0001493152-21-000130","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315221000130/ownership.xml","form_type":"4"}},{"id":3103915,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-06-19T21:30:11.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. Vesting is performance based and tied to achievement of positive topline ENHANCE-IT data (the \"Milestone\"). The option vests as to 1/3 upon achievement of the Milestone, with the remaining options to vest 1/3 on the first anniversary of such Milestone and 1/3 on the second anniversary of such Milestone."}],"balance_after":250000,"derivative":{"exercise_price":0.815,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-20-011532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220011532/ownership.xml","form_type":"4"}},{"id":3321464,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-01-03T21:05:47.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2021 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2021."}],"balance_after":500000,"derivative":{"exercise_price":2.27,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-20-000120","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220000120/ownership.xml","form_type":"4"}},{"id":3628484,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23996,"kind":"person","name":"Ferguson James J. III","position":1,"cik":"0001769041","reported_name":"Ferguson James J. III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-02-27T21:58:21.000Z","date":"2019-02-25","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 25% of the shares on February 25, 2020 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on March 31, 2020. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan."}],"balance_after":350000,"derivative":{"exercise_price":1.09,"expiration_date":"2029-02-24","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0000905718-19-000260","document":"matinas_form4feb252019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571819000260/matinas_form4feb252019.xml","form_type":"4"}}]}